Emil Bulatov
Emil Bulatov
Verified email at kpfu.ru
Title
Cited by
Cited by
Year
Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation
E Bulatov, A Ciulli
Biochemical Journal 467 (3), 365-386, 2015
1132015
The biological basis and clinical symptoms of CAR-T therapy-associated toxicites
A Titov, A Petukhov, A Staliarova, D Motorin, E Bulatov, O Shuvalov, ...
Cell death & disease 9 (9), 1-15, 2018
362018
Binding and purification of plasmid DNA using multi-layered carbon nanotubes
II Shakhmaeva, ER Bulatov, OV Bondar, DV Saifullina, M Culha, ...
Journal of biotechnology 152 (3), 102-107, 2011
232011
Effect of size and protein environment on electrochemical properties of gold nanoparticles on carbon electrodes
TI Abdullin, OV Bondar, II Nikitina, ER Bulatov, MV Morozov, ...
Bioelectrochemistry 77 (1), 37-42, 2009
202009
Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase suppressor of cytokine signaling 2 (SOCS2)-elongin bc-cullin 5-ring box protein 2 (RBX2)
E Bulatov, EM Martin, S Chatterjee, A Knebel, S Shimamura, ...
Journal of Biological Chemistry 290 (7), 4178-4191, 2015
192015
Small molecule modulators of RING-type E3 ligases: MDM and Cullin families as targets
E Bulatov, A Zagidullin, A Valiullina, R Sayarova, A Rizvanov
Frontiers in pharmacology 9, 450, 2018
132018
Serendipitous SAD solution for DMSO-Soaked SOCS2-elonginC-elonginB crystals using covalently incorporated dimethylarsenic: Insights into substrate receptor conformational …
MS Gadd, E Bulatov, A Ciulli
PloS one 10 (6), e0131218, 2015
112015
Promising new therapeutic targets for regulation of inflammation and immunity: RING-type E3 ubiquitin ligases
E Bulatov, A Valiullina, R Sayarova, A Rizvanov
Immunology Letters 202, 44-51, 2018
102018
Ubiquitin-Proteasome System: Promising Therapeutic Targets in Autoimmune and Neurodegenerative Diseases
E Bulatov, S Khaiboullina, H José dos Reis, A Palotás, K Venkataraman, ...
Bionanoscience, 2016
102016
Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
A Titov, A Valiullina, E Zmievskaya, E Zaikova, A Petukhov, R Miftakhova, ...
Cancers 12 (1), 125, 2020
92020
Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors
E Bulatov, R Sayarova, R Mingaleeva, R Miftakhova, M Gomzikova, ...
Cell death discovery 4 (1), 1-9, 2018
82018
Endonuclease from Gram-negative bacteria Serratia marcescens is as effective as pulmozyme in the hydrolysis of DNA in sputum
G Vafina, E Zainutdinova, E Bulatov, MN Filimonova
Frontiers in pharmacology 9, 114, 2018
32018
Identification and Validation of a Series of P53-MDM2 and P53-MDMX Protein-protein Interaction Inhibitors (MPhil Thesis)
E Bulatov
University of Newcastle upon Tyne, 2011
22011
Effect of Nutlin-3a, RG-7112, Carfilzomib and MG-132 on accumulation of p53 in eukaryotic HEK293 cell line
I Glagoleva, A Kudriaeva, A Belogurov, A Rizvanov, E Bulatov
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 48, 100-100, 2018
12018
A One-Step Protocol for Chromatographic Purification of Non-recombinant Exogenous Bacterial Enzyme: Nuclease of Serratia marcescens
G Vafina, E Bulatov, E Zaynutdinova, M Filimonova
Bionanoscience, 2016
12016
Simultaneous detection of distinct DNA lesions on carbon nanotube modified electrode
II Nikitina, OV Bondar, ER Bulatov, TI Abdullin
The Second St. Petersburg International Conference on Nanobiotechnologies …, 2008
12008
Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
R Mirgayazova, R Khadiullina, V Chasov, R Mingaleeva, R Miftakhova, ...
Genes 11 (6), 704, 2020
2020
2003P Expression of mutant p53 affects cancer cell sensitivity to topotecan
R Mingaleeva, A Sagdeeva, R Sayarova, E Bulatov, RR Miftakhova, ...
Annals of Oncology 30 (Supplement_5), mdz269. 021, 2019
2019
Novel Isatin-based activator of p53 transcriptional functions in tumor cells
R Mirgayazova, R Khadiullina, R Mingaleeva, V Chasov, M Gomzikova, ...
Molecular Biology Research Communications 8 (3), 119, 2019
2019
Selective small molecule stabilisers/activators of p53 (Y220C) mutant
R Sayarova, R Nazyrova, R Mingaleeva, O Kartseva, I Glagoleva, ...
CELL DEATH DISCOVERY 5, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20